Johnson & Johnson vaccine receives green light from European regulator
The EMA believes that the overall benefit-risk balance of using Johnson & Johnson's vaccine remains positive.
AP - David Zalubowski
Text by: RFI Follow
2 min
For the European Medicines Agency (EMA), the Johnson & Johnson vaccine against Covid-19, on which many countries rely to speed up immunization campaigns, can be used, due to a favorable benefit / risk ratio .
Publicity
Read more
In a ruling on Tuesday, the European Medicines Agency ruled that blood clots that have occurred in a few vaccinated people should be listed as a "
very rare
" side effect of the Johnson & Johnson vaccine.
"
The EMA finds a possible link with very rare cases of unusual blood clots associated with low blood platelets
," said the European regulator, adding that this "
confirms that the overall benefit-risk balance remains positive
".
The CFO of Johnson & Johnson (J&J) had previously said the laboratory remained "
fully confident
" about its vaccine and hoped to find "
very soon
" a solution with regulators on its use,
currently suspended in Europe and the United States
.
This decision was eagerly awaited by several European countries, including France, which rely on the J&J vaccine, having the advantage of requiring only one dose, to speed up their immunization campaign.
AstraZeneca and Janssen's anti-Covid vaccines are "
essential
" to achieve the objectives of the vaccination campaign in France, the Ministry of Health said on Tuesday.
►
To read also: France: vaccination opens to all over 55 years
In the United States, health authorities recommended last Tuesday "
a pause
" in its use to investigate the appearance of serious cases of blood clots.
However, its use should be re-authorized, perhaps accompanied by "
restrictions,
" and a decision should be made public by Friday, White House medical adviser Anthony Fauci said on Sunday.
(
With
AFP)
Newsletter
Receive all international news directly in your mailbox
I subscribe
Follow all the international news by downloading the RFI application
google-play-badge_FR
Coronavirus
Health and medicine